[Retracted] Analysis of the Correlation of Basic Fibroblast Growth Factor in Serum of Patients with Diffuse Large B-Cell Lymphoma with Clinicopathological Efficacy and International Prognostic Index

Table 2

Serum bFGF levels in patients with different clinical stages of DLBCL (ng/mL,  ± s).

Group	Before the treatment	After the treatment
Stage I DLBCL patients group (n = 21)	19.36 ± 2.04	15.17 ± 1.15
Stage II DLBCL patients group (n = 25)	22.13 ± 2.11^a	18.95 ± 1.52^a
Stage III DLBCL patients group (n = 30)	27.04 ± 2.32^ab	20.27 ± 1.61^ab
Stage IV DLBCL patients group (n = 39)	33.18 ± 2.46^abc	24.47 ± 1.79^abc
F	8.176	7.549
	＜0.001	＜0.001